Like ty
DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low
After reviewing the FDA's information requests and considering all other options, DBV Technologies h
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
6
举报
登录后可参与评论
![empty](https://c1.itigergrowtha.com/community/assets/media/empty-default.06ba11e0.png)
暂无评论